JCM | Free Full-Text | Antiarrhythmic Effect of Sacubitril-Valsartan: Cause or Consequence of Clinical Improvement?
Estimating the Lifetime Benefits of Treatments for Heart Failure - ScienceDirect
A randomized clinical trial on the short‐term effects of 12‐week sacubitril/ valsartan vs. enalapril on peak oxygen consumption in patients with heart failure with reduced ejection fraction: results from the ACTIVITY‐HF study -
Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF - ScienceDirect
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction - ScienceDirect
Emerging Treatment Approaches to Improve Outcomes in Patients with Heart Failure | Cardiology Discovery
Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF - ScienceDirect
IJERPH | Free Full-Text | ARNI in HFrEF—One-Centre Experience in the Era before the 2021 ESC HF Recommendations
Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF | JACC: Heart Failure
Forest plot of indirect comparisons used to estimate the effects of... | Download Scientific Diagram
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial - ScienceDirect
Insights into implementation of sacubitril/valsartan into clinical practice - Martens - 2018 - ESC Heart Failure - Wiley Online Library
Perks and Pitfalls of Performance-Linked Reimbursement for Novel Drugs: The Case of Sacubitril-Valsartan | Circulation: Cardiovascular Quality and Outcomes
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction | Heart
Estimating the Long-Term Treatment Benefits of Sacubitril–Valsartan | NEJM
JCM | Free Full-Text | Looking for a Tailored Therapy for Heart Failure: Are We Capable of Treating the Patient Instead of the Disease?
Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial | JACC: Heart Failure
Frontiers | Sacubitril/Valsartan Reduces Fibrosis and Alleviates High-Salt Diet-Induced HFpEF in Rats
Kidney Research and Clinical Practice
Clinical outcomes of Sacubitril/Valsartan in patients with acute heart failure: A multi-institution study - eClinicalMedicine
Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF | JACC: Heart Failure
Sacubitril/Valsartan For Heart Failure & Ejection Fraction
The Efficacy and Safety of Sacubitril/Valsartan in Heart Failure Patients: A Review - Rui Zhang, Xiaotong Sun, Ya Li, Wenzheng He, Hongguang Zhu, Baoshan Liu, Aiyuan Zhang, 2022
IJMS | Free Full-Text | Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure
Frontiers | Sacubitril-Valsartan Compared With Enalapril for the Treatment of Heart Failure: A Decision-Analytic Markov Model Simulation in China
